Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
-15.84%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$103B
AUM Growth
-$27.2B
Cap. Flow
-$264M
Cap. Flow %
-0.26%
Top 10 Hldgs %
15.13%
Holding
4,047
New
575
Increased
1,477
Reduced
1,329
Closed
645

Sector Composition

1 Healthcare 25.43%
2 Technology 12.73%
3 Consumer Staples 9.8%
4 Financials 8.2%
5 Utilities 8.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SNDL icon
3176
Sundial Growers
SNDL
$607M
$133K ﹤0.01%
+20,750
New +$133K
FET icon
3177
Forum Energy Technologies
FET
$325M
$132K ﹤0.01%
37,271
+8,489
+29% +$30.1K
LPCN icon
3178
Lipocine
LPCN
$16.3M
$132K ﹤0.01%
16,183
-95,656
-86% -$780K
RNGR icon
3179
Ranger Energy Services
RNGR
$301M
$131K ﹤0.01%
32,287
+2,801
+9% +$11.4K
NBRV
3180
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$131K ﹤0.01%
910
-3,409
-79% -$491K
NINE icon
3181
Nine Energy Service
NINE
$30.5M
$130K ﹤0.01%
160,700
+50,500
+46% +$40.9K
AEHR icon
3182
Aehr Test Systems
AEHR
$790M
$129K ﹤0.01%
77,299
-301
-0.4% -$502
DXLG icon
3183
Destination XL Group
DXLG
$67.9M
$128K ﹤0.01%
365,811
+150,523
+70% +$52.7K
RKDA icon
3184
Arcadia Biosciences
RKDA
$4.35M
$126K ﹤0.01%
+1,102
New +$126K
BCML icon
3185
BayCom
BCML
$329M
$125K ﹤0.01%
10,400
-34,700
-77% -$417K
CAPR icon
3186
Capricor Therapeutics
CAPR
$289M
$124K ﹤0.01%
103,615
+19,830
+24% +$23.7K
CARE icon
3187
Carter Bankshares
CARE
$450M
$124K ﹤0.01%
+13,487
New +$124K
FLGT icon
3188
Fulgent Genetics
FLGT
$667M
$124K ﹤0.01%
11,521
-76,900
-87% -$828K
IMXI icon
3189
International Money Express
IMXI
$430M
$124K ﹤0.01%
+13,615
New +$124K
MCF
3190
DELISTED
Contango Oil & Gas Co.
MCF
$123K ﹤0.01%
+82,066
New +$123K
XBIO icon
3191
Xenetic Biosciences
XBIO
$4.6M
$122K ﹤0.01%
16,412
+4,332
+36% +$32.2K
REV
3192
DELISTED
Revlon, Inc.
REV
$122K ﹤0.01%
+11,196
New +$122K
APM icon
3193
Aptorum Group
APM
$12.3M
$121K ﹤0.01%
+3,304
New +$121K
SOLO
3194
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$121K ﹤0.01%
+116,153
New +$121K
DX
3195
Dynex Capital
DX
$1.65B
$120K ﹤0.01%
+11,500
New +$120K
DSS icon
3196
DSS Inc
DSS
$11.3M
$118K ﹤0.01%
1,067
+1,012
+1,840% +$112K
CARM icon
3197
Carisma Therapeutics
CARM
$16.4M
$117K ﹤0.01%
+10,411
New +$117K
MTL.PR
3198
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$117K ﹤0.01%
334,802
+9,202
+3% +$3.22K
PPBT
3199
Purple Biotech
PPBT
$1.7M
$116K ﹤0.01%
+1,895
New +$116K
GROW icon
3200
US Global Investors
GROW
$31.7M
$115K ﹤0.01%
118,326
+14,500
+14% +$14.1K